250 related articles for article (PubMed ID: 23470966)
1. Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.
Miao YR; Eckhardt BL; Cao Y; Pasqualini R; Argani P; Arap W; Ramsay RG; Anderson RL
Clin Cancer Res; 2013 Apr; 19(8):2107-16. PubMed ID: 23470966
[TBL] [Abstract][Full Text] [Related]
2. Proapoptotic Cyclic Peptide BC71 Targets Cell-Surface GRP78 and Functions as an Anticancer Therapeutic in Mice.
Kao C; Chandna R; Ghode A; Dsouza C; Chen M; Larsson A; Lim SH; Wang M; Cao Z; Zhu Y; Anand GS; Ge R
EBioMedicine; 2018 Jul; 33():22-32. PubMed ID: 29907328
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
Al-Hashimi AA; Lebeau P; Majeed F; Polena E; Lhotak Š; Collins CAF; Pinthus JH; Gonzalez-Gronow M; Hoogenes J; Pizzo SV; Crowther M; Kapoor A; Rak J; Gyulay G; D'Angelo S; Marchiò S; Pasqualini R; Arap W; Shayegan B; Austin RC
J Biol Chem; 2017 Dec; 292(51):21180-21192. PubMed ID: 29066620
[TBL] [Abstract][Full Text] [Related]
4. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.
Cai Y; Zheng Y; Gu J; Wang S; Wang N; Yang B; Zhang F; Wang D; Fu W; Wang Z
Cell Death Dis; 2018 May; 9(6):636. PubMed ID: 29802332
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
[TBL] [Abstract][Full Text] [Related]
6. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.
Arap MA; Lahdenranta J; Mintz PJ; Hajitou A; Sarkis AS; Arap W; Pasqualini R
Cancer Cell; 2004 Sep; 6(3):275-84. PubMed ID: 15380518
[TBL] [Abstract][Full Text] [Related]
7. A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78.
Shin J; Kim B; Lager TW; Mejia F; Guldner I; Conner C; Zhang S; Panopoulos AD; Bilgicer B
Nanoscale; 2023 Aug; 15(32):13322-13334. PubMed ID: 37526009
[TBL] [Abstract][Full Text] [Related]
8. Quantum dot-conjugated anti-GRP78 scFv inhibits cancer growth in mice.
Xu W; Liu L; Brown NJ; Christian S; Hornby D
Molecules; 2012 Jan; 17(1):796-808. PubMed ID: 22249409
[TBL] [Abstract][Full Text] [Related]
9. A peptidic unconjugated GRP78/BiP ligand modulates the unfolded protein response and induces prostate cancer cell death.
Maddalo D; Neeb A; Jehle K; Schmitz K; Muhle-Goll C; Shatkina L; Walther TV; Bruchmann A; Gopal SM; Wenzel W; Ulrich AS; Cato AC
PLoS One; 2012; 7(10):e45690. PubMed ID: 23049684
[TBL] [Abstract][Full Text] [Related]
10. Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3.
Yao X; Liu H; Zhang X; Zhang L; Li X; Wang C; Sun S
PLoS One; 2015; 10(5):e0125634. PubMed ID: 25973748
[TBL] [Abstract][Full Text] [Related]
11. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells.
Tseng CC; Zhang P; Lee AS
Neoplasia; 2019 Aug; 21(8):837-848. PubMed ID: 31306849
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer.
Cook KL; Soto-Pantoja DR; Clarke PA; Cruz MI; Zwart A; Wärri A; Hilakivi-Clarke L; Roberts DD; Clarke R
Cancer Res; 2016 Oct; 76(19):5657-5670. PubMed ID: 27698188
[TBL] [Abstract][Full Text] [Related]
13. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts.
Anbalagan M; Ali A; Jones RK; Marsden CG; Sheng M; Carrier L; Bu Y; Hangauer D; Rowan BG
Mol Cancer Ther; 2012 Sep; 11(9):1936-47. PubMed ID: 22784709
[TBL] [Abstract][Full Text] [Related]
14. Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway.
Zheng Y; Liu P; Wang N; Wang S; Yang B; Li M; Chen J; Situ H; Xie M; Lin Y; Wang Z
Oxid Med Cell Longev; 2019; 2019():8781690. PubMed ID: 31531187
[TBL] [Abstract][Full Text] [Related]
15. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.
Dong D; Ni M; Li J; Xiong S; Ye W; Virrey JJ; Mao C; Ye R; Wang M; Pen L; Dubeau L; Groshen S; Hofman FM; Lee AS
Cancer Res; 2008 Jan; 68(2):498-505. PubMed ID: 18199545
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression.
Bailey-Downs LC; Thorpe JE; Disch BC; Bastian A; Hauser PJ; Farasyn T; Berry WL; Hurst RE; Ihnat MA
PLoS One; 2014; 9(5):e98624. PubMed ID: 24878664
[TBL] [Abstract][Full Text] [Related]
17. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
18. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
20. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
